57. Trinity Partners

Revenue Growth: 45%

HQ: Waltham, Mass.

Trinity Partners provides commercialization strategy and services to pharmaceutical, biotech, medical device, and diagnostic clients worldwide. Trinity is a leader in creating innovative, evidence-based solutions that drive business strategy and impact bottom lines. Dave Fitzhenry, CEO & Managing Partner of Trinity Partners sat down with Consulting to discuss the firm's financial performance. 

Consulting: What were the main factors that contributed to your firm's exceptional growth? 

Fitzhenry: Throughout Trinity's history, we have emphasized hiring the best talent, focusing on development, and setting our employees up for future professional success. From an internal perspective, we hold ourselves to exceptionally high standards in order to support individuals' career growth, as well as the continued growth of our business. Trinity's vast repository of market based knowledge, innovative  processes and products combined with the individual talent and expertise we bring on an ongoing basis, ensure a strong value proposition to our clients. 

Consulting: How is this year shaping up for your firm?

Fitzhenry: This year has been pivotal in Trinity's history. We acquired TGaS Advisors, the leading benchmarking firm for commercial organizations in the life sciences industry. The acquisition marks another proof point in Trinity Partners' overarching growth strategy of building a complete solution set for the most critical issues facing manufacturers today. This acquisition builds upon previous successes and momentum. Trinity also expanded in the U.S. and globally, opening an office in Gurgaon, India to complement our existing offices in Waltham, New York, Princeton, N.J. Philadelphia and San Francisco. 

Consulting:  How would you describe your firm's outlook for 2019? 

Fitzhenry: Trinity's having an exceptional 2018, exceeding even our most aggressive organic growth targets all while recapitalizing the company and making our first acquisition. For 2019, we couldn't be more excited about our prospects for growth. Successfully launching and maximizing assets has never been more challenging for our clients, and Trinity is committed to breaking new ground to help our clients overcome these challenges. 

Consulting: What would you say are your firm's biggest challenges?

Fitzhenry: Our vision is to lead transformation in the life sciences industry, guiding our clients with strategy and insights that support the development and delivery of life changing innovations to patients around the globe. Our biggest challenges go beyond 2019 and the focal points will be managing rapid growth while retaining a vibrant, people-first culture of innovation, which is at the core of Trinity's focus. After our recent acquisition of TGaS Advisors, we will work to integrate their strong talent and benchmarking capabilities into our existing service offerings all while continuing to innovate on our combined platforms to develop best in class solutions.  

Consulting:  What does being named one of Consulting's Fastest Growing Firms mean to your firm?

Fitzhenry: For us, being named one of Consulting's Fastest Growing Firms for the fourth year in a row is incredibly exciting for us, and a tribute to the thoughtfulness and dedication of our teams. Growth is not easy, and we are transparent with our employees about many of these challenges because in the end, we're all in this together. This recognition is a demonstration of the success of our model and our commitment to culture. 

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.